KRT80 Promotes Lung Adenocarcinoma Progression and Serves as a Substrate for VCP.

Autor: Shanhua Huang^1,2, Weilai Tong³, Bowen Yang^1,2, Li Ma^1,2, Jiaming Zhang^1,2, Chunliang Wang⁴, Linlin Xu^1,2 xulinlin@ncu.edu.cn, Jinhong Mei^1,2 meijinhong@ncu.edu.cn

Publikováno v: Journal of Cancer. 2024, Vol. 15 Issue 8, p2229-2244. 16p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Characters of KRT80 and its roles in neoplasms diseases

Autor: Xin‐Yuan Wei, Jie Zhao, Hao‐Bin Tong, Shang‐Jie Cheng, Na He, Fei‐Xue Song

Publikováno v: Cancer Medicine, Vol 12, Iss 13, Pp 13991-14003 (2023)

Abstract Background KRT80 is a human epithelial intermediate filament type II gene; its expression product is a component of intracellular intermediate filaments (IFs) and is involved in the assembly of the cytoskeleton. There is evidence that IFs fo

Externí odkaz: https://doaj.org/article/a2685de916024e7aa63b7d0a11e74710

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Identification of KRT80 as a Novel Prognostic and Predictive Biomarker of Human Lung Adenocarcinoma via Bioinformatics Approaches.

Autor: Jiang J; Department of Oncology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), 310000, Hangzhou, China.; The Third Clinical Medical College, Zhejiang Chinese Medical University, 310000, Hangzhou, China., Lu J; Department of Oncology, Hangzhou Traditional Chinese Medicine (TCM) Hospital Affiliated to Zhejiang Chinese Medical University, 310000, Hangzhou, China., Feng Y; Department of Oncology, Hangzhou Traditional Chinese Medicine (TCM) Hospital Affiliated to Zhejiang Chinese Medical University, 310000, Hangzhou, China., Zhao Y; The Third Clinical Medical College, Zhejiang Chinese Medical University, 310000, Hangzhou, China., Su J; The Third Clinical Medical College, Zhejiang Chinese Medical University, 310000, Hangzhou, China., Zeng T; The Third Clinical Medical College, Zhejiang Chinese Medical University, 310000, Hangzhou, China., Chen Y; The Third Clinical Medical College, Zhejiang Chinese Medical University, 310000, Hangzhou, China., Shen K; Department of Oncology, Hangzhou Traditional Chinese Medicine (TCM) Hospital Affiliated to Zhejiang Chinese Medical University, 310000, Hangzhou, China., Jia Y; Department of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, 91054, Erlangen, Germany., Lin S; Department of Oncology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), 310000, Hangzhou, China.

Publikováno v: Combinatorial chemistry & high throughput screening [Comb Chem High Throughput Screen] 2024 Jun 20. Date of Electronic Publication: 2024 Jun 20.